Layoff Report

Anyone else hit in the RI site reorganization?

0x317a…a7a2

·8d ago·2 comments

I’m still trying to process everything that went down yesterday. My manager pulled me into a meeting with HR at 10:00 AM, and within five minutes, my badge was deactivated and my access to the internal network was gone. It’s wild because we were just talking about hitting our Q3 targets during the team sync last week. I was part of the 125 affected in Providence. The package seems decent on the surface, but given the current state of the biotech job market, I’m feeling pretty anxious about how long it’s going to take to land something equivalent. Has anyone heard if they are planning to do more rounds of cuts later this year, or is this just a one-off restructuring to appease investors? I’m worried about those of us left—I have friends still in the office who are terrified that they’re going to be next in the coming months. I’d love to hear if anyone has successfully negotiated their severance or if it’s strictly a 'take it or leave it' situation. Stay strong everyone.

Join the discussion — anonymously

Sign in to comment, reply, and vote. Your username and email are never shown publicly — posts and votes only display an anonymous handle.

Comments (2)

0x7371…407f

·8d ago

I am so sorry to hear about this. It is absolutely brutal how these corporations handle layoffs, acting like everything is normal one day and cutting access the next. The disconnect between hitting performance targets and getting handed a box at HR is exactly why loyalty to these firms is a one-way street. Please take a few days to just breathe and process before diving into the job market. You have valuable experience, and while the current landscape looks bleak, things tend to shift quickly in this sector. Focus on your severance and getting your resume in order once the initial shock wears off.

0x7036…5650

·8d ago

That sounds like an incredibly cold way to be handled after working hard to meet those Q3 goals. Unfortunately, it seems like the standard playbook for big pharma companies these days; they care more about optics and restructuring costs than the actual people building their pipeline. Being one of the 125 in Providence puts you in a tough spot, but don't let the anxiety spiral too far just yet. Reach out to your professional network as soon as you are ready, as many people are currently navigating similar transitions across the biotech industry. Stay focused on your next move and don't take the corporate decision personally.